Executive Director, Business Development & Corporate Strategy

Executive Director, Business Development & Corporate Strategy

Seal Beach, California, United States

WHO WE ARE:

At Dendreon,we’retransforming the battle against cancer with personalized immunotherapy. Our flagship product, PROVENGE® (sipuleuc‑T) , was the first FDA‑approved immunotherapy for metastatic castrate‑resistant prostate cancer,utilizinga patient’s own immune cells to fight the disease.

If you’re driven by the opportunity to make a meaningful impact on cancer patients’ lives, we invite you to join our team. With Immunotherapy Manufacturing Facilities in Seal Beach, CA, and Union City, GA, a talented team of scientific, clinical, regulatory, and corporate professionals based in Seal Beach, and a commercial organization operating across the United States, Dendreon continues to advance innovation in personalized cancer treatment.

CORE VALUES:

• Put Patients First: Every day is an opportunity to improve the lives of those living with cancer.
• Act with Integrity: We commit to transparency, honesty, and always doing what’s right.
• Build Trust: Trust is earned through candid, open communication and a collaborative approach.
• Raise the Bar: We embrace continuous improvement and innovation, always striving to elevate our people.
• Drive Results: We are accountable to each other and deliver success together.

Job Summary:

The Executive Director of Business Development & Corporate Strategy is a senior enterprise leader responsible for shaping and executing Dendreon’s external growth strategy (CMS). Partnering directly with the CEO and Senior Leadership Team, this role owns the identification, evaluation, prioritization, negotiation, and execution of strategic transactions, including licensing, acquisitions, investments, strategic alliances, and CDMO partnerships.

The Executive Director will translate corporate objectives into an actionable business development and portfolio strategy, provide decision-quality recommendations to executive and board-level stakeholders, and lead cross-functional teams through high-stakes diligence and deal execution. This role requires a seasoned biotech or pharmaceutical business development executive with demonstrated success independently originating and closing material transactions which may include late-stage and commercial assets, complex therapeutic modalities, and global partners.

Key Responsibilities:

Enterprise Strategy & Portfolio Leadership

• Own and lead the enterprise-wide business development and corporate strategy agenda in alignment with Dendreon’s long-range growth objectives, portfolio priorities, and capital allocation framework.
• Serve as a trusted strategic advisor to the CEO and Senior Leadership Team, bringing forward differentiated external growth opportunities and clear recommendations on strategic fit, value creation, risk, and prioritization.
• Lead portfolio-level assessments and scenario planning across licensing, acquisitions, strategic investments, alliances, and build-versus-buy opportunities.
• Prepare and present strategic recommendations, transaction updates, investment cases, and decision materials to executive leadership, the Board of Directors, and investment committees, as applicable.

Strategic Transactions & External Innovation

• Independently originate, evaluate, prioritize, and advance a global pipeline of high-impact business development opportunities, including first-in‑class and differentiated therapeutic modalities.
• Lead the search, evaluation, and acquisition or licensing of clinical‑to commercial-stage therapeutic assets, with emphasis on late-stage Phase II/III and commercial opportunities aligned with immunotherapy, urology, oncology, and other strategic growth areas.
• Direct integrated scientific, clinical, regulatory, CMC, intellectual property, commercial, financial, and operational diligence; resolve critical issues and drive teams toward investment and transaction decisions.
• Assess complex modalities, including antibody‑drug conjugates, biologics, cell therapies, and other advanced platforms, considering scientific differentiation, development risk, manufacturability, regulatory path, commercial potential, and strategic value.
• Build executive‑level relationships with biotechnology and pharmaceutical companies, investors, venture capital and private equity firms, bankers, advisors, and other external partners to strengthen Dendreon’s access to priority opportunities.

Deal Structuring, Negotiation & Execution

• Lead complex transactions from initial engagement through valuation, term sheet, negotiation, definitive agreements, governance design, closing, and transition to alliance management or integration.
• Develop and challenge valuation models, forecasts, risk‑adjusted scenarios, transaction structures, and investment returns in partnership with Finance and other functional leaders.
• Lead negotiations with senior external counterparties and coordinate internal and external legal, financial, scientific, and operational advisors.
• Ensure clear executive alignment on deal rationale, key risks, economics, governance, decision rights, and post‑transaction accountabilities.
• Own the strategic direction and business development plan for positioning Dendreon’s manufacturing capabilities as a differentiated CDMO partner.
• Identify and build relationships with prospective CDMO clients and strategic partners, shape value propositions, and lead the development and negotiation of proposals and commercial agreements.
• Partner with Technical Operations, Quality, Regulatory, Finance, and Legal to evaluate technical feasibility, capacity, economics, operational readiness, risk, and execution requirements.
• Represent Dendreon in senior‑level client discussions, industry conferences, partnering forums, and other external engagements.

Organizational Leadership

• Provide leadership, direction, and development to business development and strategy team members and cross‑functional deal teams; establish clear priorities, governance, and accountability.
• Build scalable processes for opportunity sourcing, screening, diligence, valuation, decision‑making, transaction execution, and post‑deal handoff.
• Influence across functions and levels without direct authority, creating alignment among executive leaders and translating complex information into clear business decisions.
• Promote a rigorous, collaborative, and results‑oriented culture consistent with Dendreon’s core values.
• Other duties as assigned.

Job Requirements:

Required Experience & Skills

• 12-15+ years of progressive business development, corporate development, corporate strategy, investment, or related experience in the biotechnology or pharmaceutical industry, including significant senior leadership responsibility.
• Demonstrated success independently originating, leading, negotiating, and closing multiple complex licensing, acquisition, strategic investment, alliance, or comparable transactions with meaningful enterprise impact.
• Proven ability to set enterprise‑level strategy, prioritize competing opportunities, advise C‑suite leaders, and influence board‑level or investment committee decisions.
• Advanced degree required: MBA, PhD, MD, or equivalent advanced scientific, business, or financial training.
• Deep understanding of biopharmaceutical development and commercialization, including complex therapeutic modalities such as ADCs, biologics, cell therapies, or other advanced platforms.
• Exceptional financial and transaction acumen, including valuation modeling, risk‑adjusted analysis, deal structuring, negotiation, and assessment of strategic and financial returns.
• Executive presence and exceptional written and verbal communication skills, with the ability to represent Dendreon credibly with boards, investors, partners, advisors, and senior external counterparties.
• Demonstrated success leading multidisciplinary teams across Clinical, R&D, Technical Operations, Regulatory, Quality, Commercial, Finance, Legal, and Intellectual Property.
• Experience building, leading, and developing teams and establishing effective business development processes and governance.
• Deal sheet required, including the candidate’s role and level of ownership in sourcing, diligence, valuation, negotiation, and closing.
• Willingness to travel up to 50%+, including international travel.

Preferred Experience

• Board‑level exposure and experience presenting transaction recommendations to boards, investment committees, or comparable governance bodies.
• Direct experience developing or leading CDMO strategy, partnerships, or commercial transactions.
• Established network across biotechnology and pharmaceutical companies, venture capital, private equity, investment banking, and life sciences advisors.
• Experience in oncology, immunotherapy, urology, cellular immunotherapy, or adjacent therapeutic areas.
• Operating experience in a commercial‑stage biotechnology or biopharmaceutical company and experience in high‑growth or transformational environments.
• Global transaction experience, including international partnerships and experience with biotechnology or pharmaceutical markets in China.
• Prior experience in venture capital, private equity, investment banking, management consulting, or a comparable strategic advisory environment within life sciences.

Working Conditions and Physical Requirements:

• On‑site in Seal Beach, CA. This position is not remote.
• This position operates in a professional office environment and routinely uses standard office equipment, including computers, phones, and multifunction office devices.
• The physical demands described here are representative of those that must be met to perform the essential functions of the role.
• While performing the duties of this job, the employee is regularly required to communicate, stand, walk, use hands to handle objects, and reach with hands and arms.

CA Compensation Range

$200,890 - $275,000 USD

Voluntary Self-Identification

For government reporting purposes, we ask candidates to respond to the below self-identification survey. Completion of the form is entirely voluntary. Whatever your decision, it will not be considered in the hiring process or thereafter. Any information that you do provide will be recorded and maintained in a confidential file.

As set forth in Dendreon Pharmaceuticals LLC’s Equal Employment Opportunity policy,we do not discriminate on the basis of any protected group status under any applicable law.

A "disabled veteran" is one of the following: a veteran of the U.S. military, ground, naval or air service who is entitled to compensation (or who but for the receipt of military retired pay would be entitled to compensation) under laws administered by the Secretary of Veterans Affairs; or a person who was discharged or released from active duty because of a service‑connected disability.

A "recently separated veteran" means any veteran during the three‑year period beginning on the date of such veteran's discharge or release from active duty in the U.S. military, ground, naval, or air service.

An "active duty wartime or campaign badge veteran" means a veteran who served on active duty in the U.S. military, ground, naval or air service during a war, or in a campaign or expedition for which a campaign badge has been authorized under the laws administered by the Department of Defense.

An "Armed forces service medal veteran" means a veteran who, while serving on active duty in the U.S. military, ground, naval or air service, participated in a United States military operation for which an Armed Forces service medal was awarded pursuant to Executive Order 12985.

Voluntary Self-Identification of Disability

Form CC-305 Page 1 of 1 OMB Control Number 1250-0005 Expires 07/31/2029

Why are you being asked to complete this form? We are a federal contractor or subcontractor. The law requires us to provide equal employment opportunity to qualified people with disabilities. We have a goal of having at least 7% of our workers as people with disabilities. The law says we must measure our progress towards this goal. To do this, we must ask applicants and employees if they have a disability or have ever had one. People can become disabled, so we need to ask this question at least every five years.

Completing this form is voluntary, and we hope that you will choose to do so. Your answer is confidential. No one who makes hiring decisions will see it. Your decision to complete the form and your answer will not harm you in any way. If you want to learn more about the law or this form, visit the U.S. Department of Labor’s Office of Federal Contract Compliance Programs (OFCCP) website at

How do you know if you have a disability?

A disability is a condition that substantially limits one or more of your “major life activities.” If you have or have ever had such a condition, you are a person with a disability. Disabilities include, but are not limited to:

• Alcohol or other substance use disorder (not currently using drugs illegally)
• Autoimmune disorder, for example, lupus, fibromyalgia, rheumatoid arthritis, HIV/AIDS
• Blind or low vision
• Cancer (past or present)
• Cardiovascular or heart disease
• Celiac disease
• Cerebral palsy
• Deaf or serious difficulty hearing
• Diabetes
• Disfigurement, for example, disfigurement caused by burns, wounds, accidents, or congenital disorders
• Epilepsy or other seizure disorder
• Gastrointestinal disorders, for example, Crohn's Disease, irritable bowel syndrome
• Intellectual or developmental disability
• Mental health conditions, for example, depression, bipolar disorder, anxiety disorder, schizophrenia, PTSD
• Missing limbs or partially missing limbs
• Mobility impairment, benefiting from the use of a wheelchair, scooter, walker, leg brace(s) and/or other supports
• Nervous system condition, for example, migraine headaches, Parkinson’s disease, multiple sclerosis (MS)
• Neurodivergence, for example, attention‑deficit/hyperactivity disorder (ADHD), autism spectrum disorder, dyslexia, dyspraxia, other learning disabilities
• Partial or complete paralysis (any cause)
• Pulmonary or respiratory conditions, for example, tuberculosis, asthma, emphysema
• Short stature (dwarfism)
• Traumatic brain injury

PUBLIC BURDEN STATEMENT: According to the Paperwork Reduction Act of 1955 no persons are required to respond to a collection of information unless such collection displays a valid OMB control number. This survey should take about 5 minutes to complete.